GLP-1 Options 2026 — Honest Comparison
Which GLP-1 or dual agonist is actually worth considering at 40-60 right now? We compared the main options on real-world results, muscle preservation risk, side effects, cost, and who each suits best.
| Medication | Best For | Avg Weight Loss | Muscle Loss Risk | Side Effects | Approx Monthly Cost (2026) | Notes |
|---|---|---|---|---|---|---|
| Semaglutide (Ozempic/Wegovy) | Steady, proven results | 15-20% | High without training | Nausea, GI, fatigue | $900–1300 (brand) | Most data, widely available compounded |
| Tirzepatide (Mounjaro/Zepbound) | Maximum weight loss | 20-25%+ | High without training | Similar to sema, sometimes stronger | $1000–1400 (brand) | Currently strongest results in trials |
| Compounded versions | Cost / access | Varies by dose | Same as brand | Same + quality risk | $200–500 | Only from reputable 503B pharmacies |
| Emerging (CagriSema, etc.) | Future options | Early data strong | Unknown long-term | Still being studied | N/A yet | Watch 2027-2028 |
Our take (2026): Tirzepatide currently leads in efficacy for most people, but the muscle-loss risk at 40-60 is real and under-discussed. Anyone using these drugs needs a serious resistance training + protein protocol. Compounded versions can be legitimate but quality varies wildly — vet your pharmacy.
This is synthesis of public trial data and clinical patterns, not medical advice. Work with a clinician experienced in midlife use of these medications.
Affiliate disclosure: Some providers or tools referenced may have affiliate relationships. We only highlight options we would consider ourselves. Full standards: here.
2027 Pro Tips for This Topic
Track your progress with Oura or similar. Reassess every 90 days. Combine with resistance training and protein for best results. This is decision-grade, not fluff – use the linked tools and letter sequence.
Explore Full Pathways →Useful reading, delivered when it is ready.
Research-led. Reader-supported. No supplement-brand sponsorships.